NASDAQ:RMTI

Rockwell Medical Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy RMTI

*Your capital is at risk

$5.67

+0.0600 (+1.07%)

At Close: Jul 13, 2026

Rockwell Medical Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 94.64. In total, the insiders bought 4.83M and sold 75.62K RMTI shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	94.64
● Buy	4.83M shares
● Sell	75.62K shares
78% Buy Activity Moderate Negative Correlation
Buy Signal High Confidence Jul 01, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 94.64. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (78% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 01, 2026 Buy	Common Stock A-Award	Strobeck Mark President And CEO	CEO / President	30 000 Value: $155.7K
Jul 01, 2026 Buy	Common Stock A-Award	Timmins Megan C. EVP, Clo & Secretary	Officer	15 000 Value: $77.9K
Jul 01, 2026 Buy	Common Stock A-Award	Chole Timothy SVP And Cco	Officer	15 000 Value: $77.9K
Jul 01, 2026 Buy	Common Stock A-Award	Cooper John G Director	Director	9 633 Value: $50.0K
Jul 01, 2026 Buy	Common Stock A-Award	Lau Joan Director	Director	9 633 Value: $50.0K
Jul 01, 2026 Buy	Common Stock A-Award	Dawson Joseph H Director	Director	9 633 Value: $50.0K
Jul 01, 2026 Buy	Common Stock A-Award	Nissenson Allen Director	Director	9 633 Value: $50.0K
Jul 01, 2026 Buy	Common Stock A-Award	Radie Robert S Director	Director	9 633 Value: $50.0K
Jul 01, 2026 Buy	Common Stock A-Award	Hunter Heather Chief Operating Officer	C-Suite Officer	15 000 Value: $77.9K
Jul 01, 2026 Buy	Common Stock A-Award	Neri Jesse SVP And CFO	C-Suite Officer	15 000 Value: $77.9K
Mar 14, 2026 Sell	Common Stock F-InKind	Strobeck Mark President And CEO	CEO / President	7 333 Value: $7K
Mar 14, 2026 Sell	Common Stock F-InKind	Chole Timothy SVP And Cco	Officer	2 444 Value: $2K
Mar 14, 2026 Sell	Common Stock F-InKind	Timmins Megan C. See Remarks	Officer	3 667 Value: $3K
Mar 14, 2026 Sell	Common Stock F-InKind	Hunter Heather Chief Operating Officer	C-Suite Officer	2 444 Value: $2K
Mar 14, 2026 Sell	Common Stock F-InKind	Neri Jesse SVP And CFO	C-Suite Officer	2 444 Value: $2K
Jan 02, 2026 Sell	Common Stock S-Sale	Neri Jesse SVP And CFO	C-Suite Officer	886 Value: $740
Jan 02, 2026 Sell	Common Stock S-Sale	Hunter Heather Chief Operating Officer	C-Suite Officer	2 868 Value: $2K
Nov 18, 2025 Sell	Common Stock S-Sale	Cooper John G Director	Director	5 079 Value: $4K
Nov 17, 2025 Buy	Stock Option (Right to Buy) A-Award	Dawson Joseph H Director	Director	25 000 Value: $21.8K
Nov 17, 2025 Buy	Common Stock A-Award	Dawson Joseph H Director	Director	25 000 Value: $216.4K
Nov 17, 2025 Buy	Common Stock J-Other	Dawson Joseph H	Director	0 Value: $0
Oct 01, 2025 Sell	Common Stock S-Sale	Hunter Heather SVP, Chief Operating Officer	C-Suite Officer	2 868 Value: $3K
Oct 01, 2025 Sell	Common Stock S-Sale	Hunter Heather SVP, Chief Operating Officer	C-Suite Officer	2 868 Value: $3K
Oct 01, 2025 Sell	Common Stock S-Sale	Chole Timothy SVP And Cco	Officer	2 868 Value: $3K
Oct 01, 2025 Sell	Common Stock S-Sale	Neri Jesse SVP And CFO	C-Suite Officer	886 Value: $1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ROCKWELL MEDICAL

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stor...

Read Full Profile Here